Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation

No abstract is available for this paper.

• Publication year

  2019

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2019-02-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00228-019-02643-yPMID 30762079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year

  2018cited by this paper
• Is trough level variability the new tool for identifying patients at risk for rejection after transplantation?

  2017cited by this paper
• Association of the combination of time‐weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation

  2016cited by this paper
• Higher Variability of Tacrolimus Trough Level Increases Risk of Acute Rejection in Kidney Transplant Recipients.

  2016cited by this paper
• High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients

  2016cited by this paper
• Psychological perspective of medication adherence in transplantation

  2016cited by this paper
• A high intrapatient variability in tacrolimus exposure is associated with poor long‐term outcome of kidney transplantation

  2016cited by this paper
• Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation

  2016cited by this paper
• Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

  2016cited by this paper
• Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development

  2016cited by this paper
• Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients

  2014cited by this paper
• Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure.

  2014cited by this paper
• Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients: A Randomized Controlled Trial Using Electronic Monitoring

  2013cited by this paper
• Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats.

  2012cited by this paper
• Epigenomics and Interindividual Differences in Drug Response

  2012cited by this paper
• Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients

  2011cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

  2010cited by this paper
• High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.

  2010cited by this paper
• Explaining variability in ciclosporin exposure in adult kidney transplant recipients

  2010cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cited by this paper
• Cytochrome P450 3A4 and P‐glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea

  2005cited by this paper
• Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients

  2004cited by this paper
• Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus

  2002cited by this paper
• Effect of Low‐ and High‐Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

  2001cited by this paper
• Clinical Pharmacokinetics of Tacrolimus

  1995cited by this paper

• The importance of staying within range: associations between tacrolimus intrapatient variability and kidney transplant outcomes

  2026cites this paper
• Elevated tacrolimus exposure variability predicts transplant renal insufficiency.

  2026cites this paper
• Tacrolimus Intrapatient Variability as a Biomarker in Solid Organ Transplantation

  2025cites this paper
• Tacrolimus intrapatient variability and rejection are associated with inferior allograft outcomes after kidney transplantation

  2025cites this paper
• Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies

  2025cites this paper
• Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes

  2024cites this paper
• High Intrapatient Tacrolimus Variability and Increased Cell-Free DNA in Kidney Transplant Recipients

  2024cites this paper
• The Number of Episodes of Subtherapeutic Tacrolimus Blood Level Is Independently Associated With Reduced Kidney Graft Survival

  2024cites this paper
• Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World Data Analysis

  2024cites this paper
• Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation

  2023cites this paper
• Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study

  2023cites this paper
• The Importance Of Avoiding Time-Dependent Bias When Testing The Prognostic Value Of An Intervening Event - Two Acute Cellular Rejection Examples In Intestinal Transplantation.

  2023cites this paper
• Exposure to tacrolimus trough levels below 6 ng/ml during the first year is associated with inferior kidney graft survival

  2022cites this paper
• Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk

  2022cites this paper
• Patterns in Tacrolimus Variability and Association with De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplant Recipients

  2022cites this paper
• Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation

  2021cites this paper
• Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation

  2021cites this paper
• Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation

  2021cites this paper
• Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients

  2021cites this paper
• Combined Effect of Inter- and Intrapatient Variability in Tacrolimus Exposure on Graft Impairment Within a 3-Year Period Following Kidney Transplantation: A Single-Center Experience

  2020cites this paper
• A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation

  2020cites this paper
• Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial

  2020cites this paper
• DHPS_A_256455 151..160

  2020cites this paper
• Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective

  2020cites this paper
• Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus

  2020cites this paper